LAUSANNE, Switzerland, April 1, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made a grant of options to purchase an aggregate of 17,000 of the Company's common shares to a new employee on April 1, 2026 ("Grant"). The Grant was offered as material inducement to the employee's employment. The Grant was approved by the Compensation Committee of the Company's B

REDWOOD CITY, Calif., April 1, 2026 /PRNewswire/ -- Synthego, a pioneering leader in genome engineering solutions, today announced that the Supreme Court of the United States has denied a petition for a writ of certiorari from Agilent Technologies, Inc., effectively concluding a multi-year legal challenge and solidifying the invalidation of two Agilent CRISPR-related patents that claimed a widely used and previously known technology. The Supreme Court's decision leaves intact the June 2025 rulin

Seraphina's science-backed fatty15 C15:0 supplement has translated to strong customer retention and associated growth. SAN DIEGO, April 1, 2026 /PRNewswire/ -- Seraphina Therapeutics, with its award-winning fatty15 supplement, has been ranked the fastest-growing Health and Wellness company by Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. The company ranked No. 11 on its overall Inc. Regionals: Pacific list — the most prestigious rankin

LOS ANGELES, April 1, 2026 /PRNewswire/ -- The Seena Magowitz Foundation has launched Seena's Care Kitchen, the first weekly cooking show to provide specific nutrition, recipes and cooking tips created especially for pancreatic cancer patients, survivors and caregivers – but perfect for anyone who wants to eat healthier. Care Kitchen was created by award-winning Hollywood film, TV and commercial producer Lisa Rudin and Roger Magowitz, and is directed and produced by Top Chef director Ariel Bole

CONSHOHOCKEN, Pa., April 1, 2026 /PRNewswire/ -- Tiger BioSciences today announced the launch of carePAC™, a line of pre-configured wound care convenience kits designed to simplify dressing changes and improve access to essential wound care supplies for patients managing wounds at home. Continue Reading carePAC (PRNewsfoto/Tiger BioSciences) carePAC™ kits contain carefully selected wound care components packaged together to support consistent, patient-friendly dressing changes. By providing the

Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, the first all-in-one proactive health platform, announced a strategic partnership with GRAIL, Inc. (Nasdaq: GRAL) to bring members access to the Galleri® multi-cancer early detection (MCED) test. Timed with the start of National Cancer Prevention and Early Detection Month, the partnership reflects a s

Strategic integration advances $15 million for aging and cancer research NEW YORK, April 1, 2026 /PRNewswire/ -- The Mark Foundation for Cancer Research has announced the completion of a merger with the Samuel Waxman Cancer Research Foundation (SWCRF), formalizing a long-standing partnership rooted in a shared commitment to advancing innovative science and bringing new treatments to cancer patients. This merger follows the establishment in 2025 of the Samuel Waxman Institute for Aging & Cancer,

Headline Summary: Patients from across the United States and around the world are increasingly traveling to Los Angeles to consult with neurosurgeon Dr. Aaron Cohen-Gadol for complex brain tumors. LOS ANGELES, April 1, 2026 /PRNewswire/ -- Neurosurgeon Dr. Aaron Cohen-Gadol, founder of the ATLAS Institute of Brain & Spine in Los Angeles, is seeing a growing number of patients traveling from across the United States and internationally to seek consultation and treatment for complex brain tumors a

Adults taking Foundayo lost an average of 27 pounds on the highest dose in the ATTAIN-1 clinical trial1 Foundayo, Lilly's second FDA-approved obesity medicine, will be available via LillyDirect® with free home delivery, starting at $25 per month with commercial coverage and $149 for self-pay INDIANAPOLIS, April 1, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overwei

Most patients taking blood thinners continued treatment until death or stopped only shortly beforehand, study finds PROVIDENCE, R.I., April 1, 2026 /PRNewswire/ -- Bleeding events were far more common than clotting events among patients with cancer in the last phase of life, yet most patients taking blood-thinning medications continued treatment until death or stopped only shortly beforehand, according to a study in Annals of Family Medicine. Continue Reading This infographic shows key findings